Verdiva Bio

Developer of oral and injectable peptide therapies for metabolic diseases

placeLondon, England, United Kingdom calendar_todayFounded 2024 language verdivabio.com

Registered entities

Social engagement

Social engagement: 6.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Forbion, General Atlantic.

Investor typeCountShare
Venture capital457%
Private equity114%
Bank & private debt114%
Other / undisclosed114%

Recent activity

5 Jun 2026
Event
ADA 86th Scientific Sessions
20 May 2026
Event
American Diabetes Association 86th Scientific Sessions
27 Feb 2026
Partnership
Sciwind Biosciences
Coming soon